William Blair Forecasts Higher Earnings for Cooper Companies

The Cooper Companies, Inc. (NASDAQ:COO) – Analysts at William Blair upped their Q4 2025 earnings estimates for Cooper Companies in a report released on Monday, December 9th. William Blair analyst M. Andrew now anticipates that the medical device company will post earnings of $1.08 per share for the quarter, up from their previous forecast of $1.07. The consensus estimate for Cooper Companies’ current full-year earnings is $3.98 per share.

Other analysts also recently issued research reports about the stock. Morgan Stanley dropped their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Citigroup lowered their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a report on Friday, December 6th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Finally, StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Up 0.2 %

Shares of Cooper Companies stock opened at $99.28 on Wednesday. The company has a 50-day simple moving average of $103.92 and a two-hundred day simple moving average of $98.88. Cooper Companies has a 52-week low of $84.26 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market capitalization of $19.77 billion, a PE ratio of 50.91, a price-to-earnings-growth ratio of 2.17 and a beta of 0.97.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business’s revenue was up 9.8% on a year-over-year basis. During the same period last year, the business earned $0.87 earnings per share.

Institutional Trading of Cooper Companies

Institutional investors and hedge funds have recently made changes to their positions in the business. LRI Investments LLC boosted its holdings in shares of Cooper Companies by 4.5% in the second quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after purchasing an additional 112 shares during the period. Mitchell & Pahl Private Wealth LLC grew its position in shares of Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock worth $881,000 after buying an additional 117 shares in the last quarter. Commonwealth Equity Services LLC grew its position in shares of Cooper Companies by 0.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after buying an additional 118 shares in the last quarter. Bleakley Financial Group LLC increased its stake in shares of Cooper Companies by 2.1% during the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after buying an additional 119 shares during the period. Finally, First Horizon Advisors Inc. raised its holdings in shares of Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock valued at $236,000 after acquiring an additional 125 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares in the company, valued at approximately $18,267,624.69. This trade represents a 41.03 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.